Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | HULL ROYAL INFIRMARY |
| Main Category: | Goods |
| Procurement Method: | Call-off from a framework agreement |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £303,750 |
| Release Date: | 3 May 2024 |
| Application Deadline: | 11 March 2024 |
| Contract Start Date: | 12 March 2024 |
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award value: | £303,750 |
| Award decision date: | 1 May 2024 |
| Award status: | Active |
This notice is being posted to inform of an award of contract to Exact Sciences UK Ltd for the supply of Oncotype DX Breast Recurrence Score Tests . The award is made via the NHS Supply Chain Framework Agreement 2023/s 000-028831.
Published contracts in the last 12 months
6
total contracts
£16.0m
total value
£2,664,968
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
11 March 2024
Closed
Estimated Value
£303,750
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Contract End Date: |
| 11 March 2027 |
| Contract Duration: | 3.0 years |
| Procurement ID (OCID): | ocds-b5fd17-2b73e421-61c8-45d7-82c5-e5eedc388360 |
| Notice Reference: | 687ab4a8-b091-4a63-b322-8ffeb5d0b020-747640 |